Sleep apnea is a condition in which breathing repeatedly stops and restarts during sleep. These pauses — called apneas — can occur dozens or even hundreds of times per night. Each interruption triggers a partial arousal as the body fights to reopen the airway, preventing the deep, restorative sleep stages the brain and body depend on for repair and regulation.
The immediate effects are familiar to most people who live with untreated sleep apnea: chronic fatigue, morning headaches, difficulty concentrating, and mood instability. But the long-term consequences extend well beyond disrupted sleep. Repeated oxygen drops and sympathetic nervous system activations throughout the night accumulate into systemic stress on the cardiovascular, metabolic, and neurological systems.
So can sleep apnea kill you? The direct answer is yes — not usually through a single acute event, but through the compounding effects of years of oxygen deprivation and physiological strain on critical body systems.
The relationship between sleep apnea and cardiovascular disease is one of the most studied in sleep medicine. Each apnea event causes oxygen saturation to drop and carbon dioxide to rise. The brain responds with a surge of sympathetic activation — the same stress response triggered by a perceived threat. Heart rate and blood pressure spike. Over thousands of repetitions, this pattern accelerates arterial inflammation, stiffness, and damage.
Untreated obstructive sleep apnea significantly increases the risk of hypertension, atrial fibrillation, coronary artery disease, heart attack, and stroke. People with severe, untreated sleep apnea have been shown to have meaningfully higher all-cause mortality rates compared to those who receive treatment. Sudden cardiac death during nighttime hours is disproportionately elevated in this population.
Disrupted sleep and chronic intermittent hypoxia also affect metabolic function. Sleep apnea is strongly associated with insulin resistance and type 2 diabetes, independently of obesity. The hormonal disruption caused by fragmented sleep — including altered cortisol patterns, reduced growth hormone release, and increased ghrelin — contributes to weight gain, metabolic dysregulation, and difficulty managing blood sugar even with appropriate dietary habits.
The brain is acutely sensitive to oxygen levels. Chronic intermittent hypoxia — the repeated oxygen drops that characterize untreated sleep apnea — is associated with structural and functional changes in brain tissue over time. Cognitive decline, memory impairment, and increased risk of neurodegenerative conditions have all been linked to long-term untreated sleep apnea.
In the shorter term, the cognitive impairment caused by sleep apnea is substantial enough to affect driving safety, occupational performance, and quality of life in measurable ways.
Obstructive sleep apnea — the most common form — occurs when the soft tissues of the throat collapse and block the airway during sleep. The underlying vulnerability to this collapse is largely structural: a narrow upper jaw, low tongue posture, retrognathic jaw position, and reduced airway volume all increase the likelihood that the airway will obstruct when muscle tone decreases during sleep.
This structural understanding is central to the approach at Airway Health. Rather than managing the obstruction nightly with a CPAP machine, airway-focused dental care evaluates and addresses the anatomical factors that make obstruction likely. Palatal expansion increases nasal airway volume. Jaw repositioning creates more space for the tongue. Myofunctional therapy restores the muscle tone and posture that helps keep the airway open. For many patients, these structural improvements produce lasting reduction in sleep apnea severity.
If you snore regularly, wake unrefreshed despite adequate time in bed, experience daytime sleepiness, or have been told you stop breathing during sleep, an evaluation is warranted. A sleep study confirms diagnosis and severity. An airway-focused dental evaluation can determine whether structural factors are contributing and whether conservative intervention is appropriate.
Sleep apnea is not a condition to defer. The cardiovascular, metabolic, and neurological risks compound over time. Early identification and treatment — whether through CPAP, oral appliance therapy, structural expansion, or a combination — significantly reduces long-term health risk.
